Pfizer has agreed to pay $430 million (245 million pounds) and plead guilty to criminal charges for illegally marketing an epilepsy drug for unapproved uses such as migraines and pain, U.S. prosecutors say...The company's Warner-Lambert division promoted the drug, Neurontin, for uses it had no scientific evidence to support...[also refers to TAP Pharmaceuticals (joint venture Abbott Laboratories & Takeda Chemical Industries)]